ArticleBiodegradation2026
Integrated metabolomic and whole genomic profiling for unravelling the biodegradation mechanism of polycyclic aromatic hydrocarbons by the paddy rhizobacteria: Priestia aryabhattai BMRS3B.
Article in Biodegradation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Polycyclic Aromatic Hydrocarbons (PAHs) are hazardous organic pollutants known for their extreme toxic implications to living beings. Their potential carcinogenicity is the major problem related to hydrocarbon contamination. The development of efficient remedy for its removal remains a challenge. Microbial degradation represents an eco-sustainable strategy to detoxify these persistent pollutants. This study employs a novel and combined approach of metabolomic and genomic (whole genome sequencing) analyses to elucidate the mechanisms involved in the biodegradation of naphthalene, phenanthrene and fluorene by Priestia aryabhattai BMRS3B. Remarkably, BMRS3B sustains its growth and efficiently utilised naphthalene, phenanthrene and fluorene at concentrations up to 100 mgmL⁻
Indexed as
Identifiers
42829888What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.